About Us

PHARMARTE S.r.l. is a pharmaceutical company of the latest generation, the one that is committed to finding effective therapeutic solutions but without side effects and harmful. Born in 2006 PHARMARTE can count on a research staff that has a long experience and profound expertise in the fields of pharmaceutical research and the development of effective active ingredients. The integrative formulations put on the market are the result of a meticulous study of the pathophysiology and of the pathogenetic mechanisms underlying the problems addressed.

Where we are present

In ITALY, distribution and marketing is present throughout the national territory.
Pharmarte is already present abroad with its products in VietnamUzbekhstan and Kazakhstan.

Our products

12 December 2019


VITADSUN® is a food supplement in buccal granules based on 50 mcg of vitamin D3 (cholecalciferol), 225 mg of magnesium and 90 mcg of vitamin K2. […]
25 September 2017

Semel® Oro

The new formulation in soluble granules for easier intake of the product. SEMEL Gold with 450 mg of magnesium and 150 mg of α-lipoic acid – […]
4 August 2017

MTHFR Prevent ® Plus

MTHFR Prevent ® Plus is a Food for Special Medical Purposes used for the dietary management of hyperhomocysteinemia arising from a verified genetic defect associated with Methyl-Tetrahydrofolate Reductase (MTHFR). […]
4 August 2017

MTHFR Prevent®

MTHFR Prevent ® Food supplement based on vitamins B2, B6, B12, L-5-methytetrahydrofolate and zinc. Product information: Vitamins B6, B12 and L-5-methyltetrahydrfolate promote the normal functioning of the homocysteine metabolism. […]
4 August 2017

Inotir® Orosolubile

Food supplement based on myo-inositol, L-tyrosine, chromium, selenium and folic acid. Product information: The inositol contained in INOTIR™ acts on both on insulin receptors and insulin […]
4 August 2017


Food supplement based on magnesium and α-lipoic acid. Product information: All the components in Semel™ contribute to a product that has marked antioxidant characteristics and neurovascular […]